Question to the Foreign, Commonwealth & Development Office:

To ask Her Majesty's Government what assessment they have made of the effectiveness of the COVAX scheme; and whether they plan to propose any reforms to the scheme.

The UK is committed to ending the acute phase of the pandemic as soon as possible, and strongly supports the COVAX Facility as a mechanism to enable this. We are among the largest donors to COVAX's Advance Market Commitment, committing £548 million that will help supply at least 1.8 billion COVID-19 vaccines to up to 92 low- and middle-income countries by early 2022. The UK will also donate 100 million COVID-19 vaccines to countries in need, 80% of which will go through COVAX.

COVAX has an ongoing monitoring and evaluation workstream, and shares results data regularly with stakeholders. FCDO officials are planning to undertake an annual review of the UK's COVAX funding at the start of 2022, and the key findings and recommendations of the review will be available on FCDO's DevTracker.